• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

The Vision Care Institute launches UV app

Article

Eyecare professionals have a new tool to help them educate patients about UV exposure, courtesy of The Vision Care Institute.

Jacksonville, FL-Eyecare professionals have a new tool to help them educate patients about UV exposure, courtesy of The Vision Care Institute.

Both eyecare practitioners and their staffs can use this tool during examinations and follow-up visits to help patients better understand the risks of sun exposure and how to better protect themselves.

The Vision Care Institute UV Protection App  can demonstrate:

• Who needs UV protection

• Cumulative ocular effects of UV

• Impact of environmental ocular exposure

• Preventative measures for UV protection

The app is free and designed specifically for iPad usage. Download it via the Apple App store.

“It is important we educate patients about the simple methods they should use to help protect their eyes and the eyes of their families all year-round,” says Sheila Hickson-Curran, BSc(Hons), MCOptom, FAAO, DipCCLR,  director, global strategic medical affairs, Johnson & Johnson Vision Care, Inc. “This new app can be a valuable teaching tool for practitioners to help patients understand why protecting their eyes is as important as protecting their skin.”

According to the company, the app is not intended as, and does not constitute medical or optometric advice. It is available only in the U.S. App Store at this time.

The Vision Care Institute is part of the Johnson & Johnson Family of Companies, which also includes Johnson & Johnson Vision Care, Inc.

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
© 2024 MJH Life Sciences

All rights reserved.